These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7111067)

  • 1. [Effect of low-molecular uremic toxins on the metabolic systems of human erythrocytes].
    Kopczyński Z
    Pol Tyg Lek; 1982 Mar; 37(1):21-4. PubMed ID: 7111067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current views on uremic toxins (comprehensive review)].
    Nádvorníková H; Schück O
    Vnitr Lek; 1976 Oct; 22(10):1023-9. PubMed ID: 790758
    [No Abstract]   [Full Text] [Related]  

  • 3. The red blood cell as a model for the study of uremic toxins.
    Smith EK; Welt LG
    Arch Intern Med; 1970 Nov; 126(5):827-30. PubMed ID: 4248903
    [No Abstract]   [Full Text] [Related]  

  • 4. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uremic toxin and nitrogen metabolism].
    Ando A; Urakabe S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):415-7. PubMed ID: 988344
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte transport of middle molecular substances.
    Gajdos M; Spustová V; Geryková M; Dzúrik R
    Proc Eur Dial Transplant Assoc; 1981; 18():183-7. PubMed ID: 7329966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.
    Gallice P; Lai E; Brunet P; Berland Y; Elsen R; Crevat A
    Int J Artif Organs; 1993 Mar; 16(3):120-2. PubMed ID: 8390969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alteration of membrane lipid fractions and the life span of the erythrocyte in uremia].
    Mori M
    Nihon Jinzo Gakkai Shi; 1976 Dec; 18(12):803-12. PubMed ID: 1035957
    [No Abstract]   [Full Text] [Related]  

  • 9. Uremic toxins.
    Balestri PL; Biagini M; Rindi P; Giovannetti S
    Arch Intern Med; 1970 Nov; 126(5):843-5. PubMed ID: 5475707
    [No Abstract]   [Full Text] [Related]  

  • 10. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of uremic middle molecules on the activity of erythrocyte lactate dehydrogenase (LDH)].
    Severini G; Malaguti-Aliberti L
    Ann Ist Super Sanita; 1985; 21(3):357-61. PubMed ID: 3834809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the significance of middle molecular retention products as uremia toxins].
    Goubeaud G; Leber HW; Schott HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, small molecular compounds].
    Orita Y; Ando A
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1545-9. PubMed ID: 2950190
    [No Abstract]   [Full Text] [Related]  

  • 15. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
    Nesse AB; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent progress in the analysis of uremic toxins by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2600-6. PubMed ID: 19083276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins].
    Wratten ML; Sereni L; Lupotti M; Ghezzi PM; Atti M; Formica M
    G Ital Nefrol; 2004; 21 Suppl 30():S67-70. PubMed ID: 15747308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effects of low-molecular uraemic toxins on the activity of 3-phospho-D-glycerol aldehyde dehydrogenase (E.C.1.2.1.12) in human erythrocytes.
    Kopczyński Z; Dryl T; Chmiel J
    Acta Physiol Pol; 1984; 35(5-6):539-45. PubMed ID: 6100768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure.
    Sakthivel R; Farooq SM; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2007 Jul; 382(1-2):1-7. PubMed ID: 17449019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.